Sanofi Enlisted Third Parties To Influence The FDA
9 CommentsBy Ed Silverman // May 25th, 2011 // 7:55 am
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Apr | Jun » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||
• Pharma Blog » 2011
Pharmalot May, 2011 Archive
Congress Probes Pricing On Two Repurposed Drugs
11 CommentsBy Ed Silverman // May 25th, 2011 // 7:03 am
The Problem With Labeling: Too Many Side Effects
16 CommentsBy Ed Silverman // May 25th, 2011 // 7:03 am
Champagne, Anyone? Pharma Freebies Down Under
Make a commentBy Ed Silverman // May 25th, 2011 // 7:03 am
FDA Issues Draft Guidance For Investigator Conflicts
10 CommentsBy Ed Silverman // May 24th, 2011 // 10:43 am
Facebook To Pharma: Allow Comments On Pages
12 CommentsBy Ed Silverman // May 24th, 2011 // 8:19 am
Canadian Regulator May Disclose Advisor Conflicts
Make a commentBy Ed Silverman // May 24th, 2011 // 7:16 am